13G Filing: Baker Bros. Advisors and Anacor Pharmaceuticals, Inc. (ANAC)

Page 6 of 10

Page 6 of 10 SEC Filing

 

Amendment No. 2 to Schedule 13G

 

This Amendment No. 2 to Schedule 13G amends and supplements
the previously filed Schedules 13G filed by Baker Bros. Advisors LP (the “Adviser”). Baker Bros. Advisors (GP) LLC
(the “Adviser GP”), Julian C. Baker and Felix J. Baker. Except as supplemented herein, such statements, as heretofore
amended and supplemented, remain in full force and effect.

 

Item 1(a) Name of Issuer:
Anacor Pharmaceuticals, Inc. (the “Issuer”)
Item 1(b) Address of Issuer’s Principal Executive Offices:
1020 East Meadow Circle
Palo Alto, California 94303-4230
Item 2(a) Name of Person Filing:
This Schedule 13G is being filed jointly by the Adviser, the Adviser GP, Felix J. Baker and Julian C. Baker (collectively, the “Reporting Persons”).
Item 2(b) Address of Principal Business Office or, if None, Residence:
The business address of each of the Reporting Persons is:
c/o Baker Bros. Advisors LP
667 Madison Avenue, 21st Floor
New York, NY 10065
(212) 339-5690
Item 2(c) Citizenship:
The Adviser is a limited partnership organized under the laws of the State of Delaware.  The Adviser GP is a limited liability company organized under the laws of the State of Delaware. The citizenship of each of Julian C. Baker and Felix J. Baker is the United States of America.
Item 2(d) Title of Class of Securities:
Common Stock, par value $0.001 per share (“Common Stock”)
Item 2(e) CUSIP Number:
032420101
Page 6 of 10 Pages

Follow Anacor Pharmaceuticals Inc. (NASDAQ:ANAC)

Page 6 of 10